Details

NameSymbolSector
NECTAR LIFESCIENCES LIMITEDNECLIFEPharmaceuticals
Open
12.56
High
12.83
Low
12
Close
12.41
Volume
416188
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Nectar Lifesciences is  
None
Estimated Stoploss of Nectar Lifesciences is ₹  
12.83
Nectar Lifesciences has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Nectar Lifesciences is  
Unpredictableℹ
. 

Trend

Nectar Lifesciences is in  
Uptrendℹ
. 
Price of Nectar Lifesciences is  
Upℹ
 by  

7.26

%. 
Target
Buy @ 

11.1

Sell @ 

13.93

Current @ 

12.41

Volume

The trade volumes of Nectar Lifesciences have been  
Underperformingℹ
Though the volume trend for Nectar Lifesciences appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Nectar Lifesciences is  

Up

 by  

6.19

% 

Valuation

The current market price of Nectar Lifesciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2047cr and total assets worth ₹ 2047cr, the balance sheet of Nectar Lifesciences is:  
Balancedℹ
. 
Cashflow
Nectar Lifesciences has  
Poorℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

100

%. 

(*Mar 2025)

50% i.e. ₹ 169cr earned in operatingℹ
12.13% i.e. ₹ 41cr spent in investingℹ
37.87% i.e. ₹ 128cr spent in financingℹ
0% in otherℹ
Nectar Lifesciences has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2024)

50.22% i.e. ₹ 224cr earned in operatingℹ
3.81% i.e. ₹ 17cr spent in investingℹ
45.96% i.e. ₹ 205cr spent in financingℹ
0% in otherℹ
Income
The income of Nectar Lifesciences is  

₹ 5cr

 and  

Loss

 is :  

₹ 176cr

(*Sep 2025)

Nectar Lifesciences Losses increased by:  

179.37

% and Income is Down by:  

98.22

% 

(*Sep 2025)

The income of Nectar Lifesciences is  

₹ 281cr

 and  

Loss

 is :  

₹ 63cr

(*Jun 2025)

Nectar Lifesciences Losses decreased by:  

51.54

% and Income is Down by:  

34.65

% 

(*Jun 2025)

The income of Nectar Lifesciences is  

₹ 430cr

 and  

Loss

 is :  

₹ 130cr

(*Mar 2025)

Nectar Lifesciences Losses increased by:  

1957.14

% and Income is Down by:  

5.49

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.